Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2025-05-28 2025-05-28
Drug Identification Number 00550507 00550507
Brand name TEVA-TRIACOMB TEVA-TRIACOMB
Common or Proper name TEVA-TRIACOMB CREAM TEVA-TRIACOMB CREAM
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients GRAMICIDIN NEOMYCIN TRIAMCINOLONE ACETONIDE NYSTATIN GRAMICIDIN NEOMYCIN TRIAMCINOLONE ACETONIDE NYSTATIN
Strength(s) 0.25MG 2.5MG 1MG 100000UNIT 0.25MG 2.5MG 1MG 100000UNIT
Dosage form(s) CREAM CREAM
Route of administration TOPICAL TOPICAL TOPICAL TOPICAL
Packaging size 60G, 450G 60G, 450G
ATC code D07CB D07CB
ATC description CORTICOSTEROIDS, COMB WITH ANTIBIOTICS CORTICOSTEROIDS, COMB WITH ANTIBIOTICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-03-15 2019-03-15
Remaining supply date 2019-03-15 2019-03-15
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments